Search results
What is COVID KP.3 variant? Symptoms, CDC data, what to know about the newest COVID strain
USA Today· 3 days agoThe Centers for Disease Control and Prevention said it is tracking the new COVID variant KP.3 as data shows its dominance across the United States. For the two-week period starting on May 26 ...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 2 days agoModerna will rival Pfizer and GSK, which launched their shots last year. Also, in June, Moderna and...
Pentagon ran secret anti-vax campaign to incite fear of China vaccines
Reuters· 15 hours agoThe clandestine operation has not been previously reported. It aimed to sow doubt about the safety...
Pfizer Provides Update on Phase 3 Study of Investigational Gene Therapy for Ambulatory Boys with...
Morningstar· 2 days agoPfizer Inc. (NYSE: PFE) today announced that CIFFREO, a Phase 3 global, multicenter, randomized, double-blind, placebo-controlled study evaluating the investigational mini-dystrophin ...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News· 4 days agoA combination COVID-influenza vaccine is apparently one step closer to hitting the market. Moderna,...
Results are looking promising for a combined COVID and flu vaccine. Here’s how it could benefit...
The Conversation· 20 hours agoEarlier this week, Moderna announced positive results for its phase 3 clinical trial of a combined vaccine against COVID and influenza. Combination vaccines
FDA gives nod to RSV vaccine for people in their 50s
Medical Xpress· 4 days agoDrugmaker GSK's Arexvy vaccine, as well as vaccines from Pfizer and Moderna, are already approved for use in adults 60 and older, since ...
There's another COVID variant you should know about: KP.3 now makes up 25% of COVID cases
USA Today· 6 days agoThe Centers for Disease Control and Prevention data shows that a new COVID variant, the KP.3...
Moderna price target raised at Oppenheimer after RSV vaccine approval By Investing.com
Investing.com· 3 days agoModerna price target raised at Oppenheimer after RSV vaccine approval
FDA Gives Nod to RSV Vaccine for People in Their 50s | Fox 11 Tri Cities Fox 41 Yakima
FOX 11/41 Yakima· 4 days agoDrugmaker GSK’s Arexvy vaccine, as well as vaccines from Pfizer and Moderna, are already approved...